From Harvard’s Springer Gets $51.5M From Pharmas, Others, For Latest Startup:

Tim Springer

Tim Springer—

Tim Springer is an immunologist at Harvard University and the scientific founder of Morphic Therapeutics.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!